Search
Sumario de resultados
TIpos de contenido
Fecha
-
EventEMBO Practical Course: Flow Cytometry of biological nano-particles for multi-omics analysi...
New flow cytometry strategies allow researchers to address the study of biological nano-particles (BNP) up to the single-particle level.
-
NewIt is now possible to buy COVID-19 rapid selftest with delivery in 24/ 48 h through kitan...
With a reliability close to 100% (CE marking), rapid antigen self-tests become a routine preventive act against COVID-19
-
Press releaseAseBio announces that BIOSPAIN, Spain's leading biotech event, will be held at the end of ...
BIOSPAIN will be held at the Palacio de Congresos y Auditorio de Navarra-Baluarte in Pamplona, from 27 September to 1 October 2021, following a hybrid format
-
Press releaseSpain leads research in advanced therapies with almost 120 clinical trials
Spain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.
-
NewMerck’s contribution in the field of Cultured Meat
Merck has ongoing research lines related to the management of resource scarcity and is driving innovation in the industrial field of 'clean meat' as a healthy, ethical and more planet-friendly
-
NewYsios Capital invests in Synendos Therapeutics
Synendos Therapeutics (Synendos) is a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to treat Central Nervous System (CNS) disorders
-
NewProteos Biotech inaugurates new pharmaceutical plant in Barcelona
This project will enable it to expand and improve its CMO services, supporting customers in the manufacture of sterile pharmaceutical, medical device and cosmeceutical products
-
NewQualitecFarma starts clinical operations from its headquarters in USA
The company is dedicated to providing international support to the pharmaceutical and biotechnology industry in the development of its products
-
NewBioincubator: The right platform to bring your biotech project to life
The facilities of the Biotechnology Business Incubator (Bioincubator) are fully prepared for the start of activity, with state-of-the-art laboratories and equipment and very advantageous setup
-
NewMicroomics enlarge its team with two new members this year
The Spanish company has decided to reinforce the bioinformatics-statistical analyses and customer service
-
NewBCN HEALTH has published 14 studies in 2020 assessing the incidence and costs of illness o...
The company conducted retrospective studies based on records of patients diagnosed with the different diseases and treated in public and private hospitals in Spain between 2000 and 2017
-
NewVIVEbiotech expands facilities to increase innovation and manufacturing capabilities of sp...
Versatility in the design will result in a more flexible configuration enabling the possibility of further clean rooms in the future as well as making it feasible accommodating a much larger number of
-
Press releaseSunlight to feed the world
Photonics is an industry that has aroused Merck's curiosity for more than 30 years
-
Press releaseSharing -not competing- in the fight against Covid-19
Merck is accelerating development and production, and bringing resources and expertise to help identify effective and scalable solutions to the pandemic of Covid-19
-
Press releaseORYZON receives the INNOVATIVE SME seal from the Ministry of Science and Innovation
Innovation present in Oryzon's programs in the field of epigenetics acknowledged. The company currently has 2 compounds in Phase II clinical studies, iadademstat and vafidemstat
-
-
Press releaseMDR Literature Search
This article will focus on the Systematic Scientific Literature Search and Review as part of the Clinical Evaluation process
-
-
CompanyInvivo Partners, S.G.E.I.C, S.A
-
Press releaseThe National Spanish Hospital of Paraplegics and Merck collaborate in an international res...
This collaboration responds to the high quality of the research and scientific talent of the Hospital Nacional de Parapléjicos and the commitment of the science and technology company Merck to invest
-
Press releaseMirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and Lic...
Mirum expands potential opportunities across rare disease pipeline and Vivet will lead pre-clinical development of its two gene therapy programs for PFIC3 and PFIC2